Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis - Summary - MDSpire
Advertisement
Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis
To assess the risk of SARS-CoV-2 infection and the severity of disease, specifically focusing on hospitalization rates, ICU admissions, and mortality, in prostate cancer (PCa) patients treated with androgen deprivation therapy (ADT).
Key Findings:
Six studies were included in the systematic review after screening 16 articles, highlighting a concerning trend in the risk of SARS-CoV-2 infection and severity of disease among PCa patients on ADT.
The studies evaluated the risk of SARS-CoV-2 infection and severity of disease among PCa patients on ADT, suggesting a potential link that warrants further exploration.
Potential confounding factors such as age, ischemic heart disease, and diabetes were considered in the analysis, emphasizing the need for careful interpretation of results.
Interpretation:
The findings suggest that ADT may influence the risk and severity of SARS-CoV-2 infection in PCa patients, indicating a need for further investigation to inform clinical management and treatment strategies.
Limitations:
Limited number of studies included in the meta-analysis, which may affect the generalizability of the findings.
Variability in study methodologies and definitions of severe disease, which could lead to inconsistencies in results.
Conclusion:
Further research is needed to clarify the relationship between ADT and SARS-CoV-2 infection severity in prostate cancer patients.
John D. Halamka, M.D., M.S., president of the Mayo Clinic Platform, and other Mayo Clinic experts discuss advanced telemedicine and the role this alternative care setting will play amid an evolving health care landscape. (Credit is available.)
